Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 3828-3841

  Miller, Halli E ^a   Robinson, Richard T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BONE MARROW CELL; CELL LINEAGE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IFNG GENE; IL12RB1 GENE; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOS2 GENE; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; BLOTTING, WESTERN; FLOW CYTOMETRY; GENES, RAG-1; LUNG; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM TUBERCULOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-12; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 84867598666     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00426-12     Document Type: Article

References (76)

1. Airoldi I, et al. 2009. IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. PLoS One 4:e6119. doi:10.1371/journal.pone.0006119.
2. Akahoshi M, et al. 2003. Influence of interleukin-12 receptor beta 1 polymorphisms on tuberculosis. Hum. Genet. 112:237-243.
3. Al-Muhsen S, Casanova JL. 2008. The genetic heterogeneity of Mende-lian susceptibility to mycobacterial diseases. J. Allergy Clin. Immunol.122:1043-1053.
4. Altare F, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435.
5. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973-1980.
6. Bharath S, Balasubramanian V. 2011. Pulmonary tuberculosis in the mouse, p 175-193. In Leong FJ, Dartois V, Dick T (ed), A color atlas of comparative pathology of pulmonary tuberculosis. CRC Press, Boca Raton,FL.
7. Leong FJ, Dartois V, Dick T (ed), A color atlas of comparative pathology of pulmonary tuberculosis. CRC Press, Boca Raton,FL.
8. Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF.2006. High-throughput real-time quantitative reverse transcription PCR. Curr. Protoc. Mol. Biol., chapter 15, unit 15.18. doi:10.1002/0471142727.mb1508s73.
9. Bosco N, Swee LK, Benard A, Ceredig R, Rolink A. 2010. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation. Exp. Hematol. 38:222-232.e.2. http://www.exphem.org/article/S0301-472X(09)00487-1/fulltext.
10. Bussolati B, et al. 1998. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.J. Immunol. 161:1493-1500.
11. Chua AO, et al. 1994. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153:128 -136.
12. Chua AO, Wilkinson VL, Presky DH, Gubler U. 1995. Cloning and characterization of a mouse IL-12 receptor-beta component. J. Immunol.155:4286-4294.
13. Cooper AM, et al. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
14. Cooper AM, et al. 2002. Mice lacking bioactive IL-12 can generate protective,antigen-specific cellular responses to mycobacterial infection onlyif the IL-12 p40 subunit is present. J. Immunol. 168:1322-1327.
15. de Beaucoudrey L, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205: 1543-1550.
16. de Beaucoudrey L, et al. 2010. Revisiting human IL-12Rbeta1 deficiency:a survey of 141 patients from 30 countries. Medicine (Baltimore) 89:381-402.
17. de Jong R, et al. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-1438.
18. Desvignes L, Ernst JD. 2009. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31:974 -985.
19. D'Souza CD, et al. 2000. A novel nonclassic beta2-microglobulinrestricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am. J. Respir. Cell Mol.Biol. 23:188 -193.
20. Dunn PL, North RJ. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:3428 -3437.
21. Ekkens MJ, et al. 2007. Th1 and Th2 cells help CD8 T-cell responses. Infect. Immun. 75:2291-2296.
22. Evans SE, et al. 2010. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am. J. Respir. Cell Mol. Biol. 42:40 -50.
23. Flynn JL, et al. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249 -2254.
24. Flynn JL, et al. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
25. Gallegos AM, et al. 2011. A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathog. 7:e1002052. doi:10.1371/journal.ppat.1002052.
26. + T cells in vivo. Blood 111:5008 -5016.
27. Guler ML, et al. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984 -987.
28. Holscher C, et al. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957-6966.
29. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
30. Inoue Y, et al. 1995. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis. Tuber Lung Dis. 76:230 -233.
31. Johnson CM, et al. 1997. Mycobacterium tuberculosis aerogenic rechallengeinfections in B cell-deficient mice. Tuber Lung Dis. 78:257-261.
32. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369 -377.
33. Khader SA, et al. 2011. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J. Immunol. 187:5402-5407.
34. Khader SA, et al. 2006. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203:1805-1815.
35. Khader SA, et al. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788 -795.
36. Lazarevic V, Nolt D, Flynn JL. 2005. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 175:1107-1117.
37. Ma CS, et al. 2012. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119:3997-4008.
38. Marquis JF, et al. 2008. Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice. Infect. Immun. 76:78-88.
39. McCune RM, Feldmann FM, Lambert HP, McDermott W. 1966. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123:445-468.
40. Metzger DW, et al. 1997. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur. J. Immunol. 27:1958 -1965.
41. Meyts I, et al. 2006. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J. Immunol. 177:6460-6470.
42. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-280.
43. Mohan K, Stevenson MM. 1998. Dyserythropoiesis and severe anaemia associated with malaria correlate with deficient interleukin-12 production. Br. J. Haematol. 103:942-949.
44. Mohan K, Stevenson MM. 1998. Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J. mice. Exp. Hematol. 26:45-52.
45. Moreno SE, et al. 2006. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J. Immunol. 177:3218 -3224.
46. North RJ. 1973. Importance of thymus-derived lymphocytes in cellmediated immunity to infection. Cell Immunol. 7:166 -176.
47. North RJ, Jung YJ. 2004. Immunity to tuberculosis. Annu. Rev. Immunol.22:599-623.
48. Oppmann B, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725.
49. Ordway DJ, Orme IM. 2011. Animal models of mycobacteria infection.Curr. Protoc. Immunol., chapter 19, unit 19.15. doi:10.1002/0471142735.im1905s94.
50. Pearce EL, Shen H. 2007. Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 179:2074 -2081.
51. Pfefferkorn ER. 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U. S. A. 81:908 -912.
52. Presky DH, et al. 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U. S. A. 93:14002-14007.
53. Reiley WW, et al. 2008. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl. Acad. Sci. U. S. A. 105:10961-10966.
54. Reiley WW, et al. 2010. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 107:19408 -19413.
55. Reinhardt RL, Hong S, Kang SJ, Wang ZE, Locksley RM. 2006. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 177:1618 -1627.
56. Rhoades ER, Frank AA, Orme IM. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78:57-66.
57. Robinson RT, et al. 2010. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rβ1 isoform that enhances DC migration. J. Exp. Med. 207:591-605.
58. Russell DG, Barry CE, III, Flynn JL. 2010. Tuberculosis: what we don't know can, and does, hurt us. Science 328:852-856.
59. Russell TD, et al. 2003. IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J. Immunol. 171:6866-6874.
60. Scanga CA, et al. 1999. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun. 67:4531-4538.
61. Schneider E, Tonanny MB, Lisbonne M, Leite-de-Moraes M, Dy M. 2004. Pro-Th1 cytokines promote Fas-dependent apoptosis of immature peripheral basophils. J. Immunol. 172:5262-5268.
62. Sharma M, Sharma S, Roy S, Varma S, Bose M. 2007. Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection. Immunol. Cell Biol. 85:229 -237.
63. Shi C, Shi J, Xu Z. 2011. A review of murine models of latent tuberculosis infection. Scand. J. Infect. Dis. 43:848-856.
64. Showe LC, et al. 1996. Structure of the mouse IL-12R beta 1 chain and regulation of its expression in BCG/LPS-treated mice. Ann. N. Y. Acad.Sci. 795:413-415.
65. Stetson DB, et al. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med.198:1069 -1076.
66. + T cells induce innate responses independently of pathogen. Nat. Med. 16:558 -564.
67. Sugawara I, et al. 2002. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb.) 82:97-104.
68. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc.Natl. Acad. Sci. U. S. A. 100:15818 -15823.
69. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21:713-758.
70. Taha RA, et al. 1999. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am. J. Respir. Crit. Care Med. 160:1119 -1123.
71. Torrado E, Cooper AM. 2011. What do we really know about how CD4 T cells control Mycobacterium tuberculosis? PLoS Pathog. 7:e1002196. doi:10.1371/journal.ppat.1002196.
72. Ueta C, et al. 1996. Interleukin-12 activates human gamma delta T cells:synergistic effect of tumor necrosis factor-alpha. Eur. J. Immunol. 26:3066-3073.
73. Wang X, et al. 1999. Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits. Eur. J. Immunol.29:2007-2013.
74. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14:361-368.
75. Wu C, Ferrante J, Gately MK, Magram J. 1997. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice: IL-12Rβ1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159:1658-1665.
76. Zhang H, et al. 2007. Modulation of mast cell proteinase-activated receptor expression and IL-4 release by IL-12. Immunol. Cell Biol. 85:558 -566.